Paediatric lymphoblastic T-cell leukaemia and lymphoma: One or two diseases?

British Journal of Haematology

Volumn 149, Issue 5, 2010, Pages 653-668

  Burkhardt, Birgit ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Lymphoblastic leukaemia; Lymphoblastic lymphoma; Precursor T cell

Indexed keywords

ANTINEOPLASTIC AGENT; CD47 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; NOTCH1 RECEPTOR; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN BCL 10; PROTEIN BNIP3; S PHASE KINASE ASSOCIATED PROTEIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR TAL1;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CHROMOSOME 6Q; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; GENE DELETION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; LYMPHOBLASTOMA; MINIMAL RESIDUAL DISEASE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL TRANSPLANTATION; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADOLESCENT; CHILD; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; MALE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 77952625263     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08006.x     Document Type: Review

References (105)

1. Aifantis, I., Raetz, E. Buonamici, S. (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nature Reviews. Immunology, 8, 380 390.
2. Andreasson, P., Hoglund, M., Bekassy, A.N., Garwicz, S., Heldrup, J., Mitelman, F. Johansson, B. (2000) Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias. European Journal of Haematology, 65, 40 51.
3. Asnafi, V., Beldjord, K., Boulanger, E., Comba, B., Le Tutour, P., Estienne, M.H., Davi, F., Landman-Parker, J., Quartier, P., Buzyn, A., Delabesse, E., Valensi, F. Macintyre, E. (2003a) Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood, 101, 2693 2703.
4. Asnafi, V., Radford-Weiss, I., Dastugue, N., Bayle, C., Leboeuf, D., Charrin, C., Garand, R., Lafage-Pochitaloff, M., Delabesse, E., Buzyn, A., Troussard, X. Macintyre, E. (2003b) CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood, 102, 1000 1006.
5. Asnafi, V., Beldjord, K., Libura, M., Villarese, P., Millien, C., Ballerini, P., Kuhlein, E., Lafage-Pochitaloff, M., Delabesse, E., Bernard, O. Macintyre, E. (2004) Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood, 104, 4173 4180.
6. Asnafi, V., Buzyn, A., Thomas, X., Huguet, F., Vey, N., Boiron, J.M., Reman, O., Cayuela, J.M., Lheritier, V., Vernant, J.P., Fiere, D., Macintyre, E. Dombret, H. (2005) Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood, 105, 3072 3078.
7. Asnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., Turlure, P., Leguay, T., Huguet, F., Vernant, J.P., Daniel, F., Bene, M.C., Ifrah, N., Thomas, X., Dombret, H. Macintyre, E. (2009) NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood, 113, 3918 3924.
8. Baleydier, F., Decouvelaere, A.V., Bergeron, J., Gaulard, P., Canioni, D., Bertrand, Y., Lepretre, S., Petit, B., Dombret, H., Beldjord, K., Molina, T., Asnafi, V. Macintyre, E. (2008) T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome. Clinical Cancer Research, 14, 692 700.
9. Ballerini, P., Landman-Parker, J., Cayuela, J.M., Asnafi, V., Labopin, M., Gandemer, V., Perel, Y., Michel, G., Leblanc, T., Schmitt, C., Fasola, S., Hagemejier, A., Sigaux, F., Auclerc, M.F., Douay, L., Leverger, G. Baruchel, A. (2008) Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica, 93, 1658 1665.
10. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783 1786.
11. Bernard, A., Boumsell, L., Reinherz, E.L., Nadler, L.M., Ritz, J., Coppin, H., Richard, Y., Valensi, F., Dausset, J., Flandrin, G., Lemerle, J. Schlossman, S.F. (1981) Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood, 57, 1105 1110.
12. Borowitz, M. Chan, J. (2008) T lymphoblastic leukemia/lymphoma. In : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. by S. Swerdlow, E. Campo, N. Harris, E. Jaffe, S. Pileri, H. Stein, J. Thiele J. Vardiman pp. 176 178. Internationa Agency for Resarchon Cancer
13. Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.D., Tolle, G., Happich, M., Muckenthaler, M.U. Kulozik, A.E. (2006) Activating NOTCH1 mutations predict favorable early treatment response and long term outcome in child-hood precursor T-cell lymphoblastic leukemia. Blood, 108, 1151 1157.
14. Brunning, R.D., Borowitz, M., Matutes, E., Head, D., Flandrin, G., Swerdlow, S.H., Bennet, J.M., Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J. (2001) Precursor T lymphoblastic leukeamia/lymphoblastic lymphoma. In : Tumors of Haematopoietic and Lymphoid Tissues (ed. by Jaffe, E.S., Harris, N.L., Stein, H. Vardiman, J. pp. 115 117. IARC Press
15. Burkhardt, B., Zimmermann, M., Oschlies, I., Niggli, F., Mann, G., Parwaresch, R., Riehm, H., Schrappe, M. Reiter, A. (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. British Journal of Haematology, 131, 39 49.
16. Burkhardt, B., Woessmann, W., Zimmermann, M., Kontny, U., Vormoor, J., Doerffel, W., Mann, G., Henze, G., Niggli, F., Ludwig, W.D., Janssen, D., Riehm, H., Schrappe, M. Reiter, A. (2006a) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. Journal of Clinical Oncology, 24, 491 499.
17. Burkhardt, B., Bruch, J., Zimmermann, M., Strauch, K., Parwaresch, R., Ludwig, W.D., Harder, L., Schlegelberger, B., Mueller, F., Harbott, J. Reiter, A. (2006b) Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia, 20, 1422 1429.
18. Burkhardt, B., Moericke, A., Klapper, W., Greene, F., Salzburg, J., Damm-Welk, C., Zimmermann, M., Strauch, K., Ludwig, W.D., Schrappe, M. Reiter, A. (2008) Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leukaemia & Lymphoma, 49, 451 461.
19. Burkhardt, B., Reiter, A., Landmann, E., Lang, P., Lassay, L., Dickerhoff, R., Lakomek, M., Henze, G. von Stackelberg, A. (2009) Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster Group. Journal of Clinical Oncology, 27, 3363 3369.
20. Campana, D. Coustan-Smith, E. (2004) Minimal residual disease studies by flow cytometry in acute leukemia. Acta Haematologica, 112, 8 15.
21. Cave, H., Suciu, S., Preudhomme, C., Poppe, B., Robert, A., Uyttebroeck, A., Malet, M., Boutard, P., Benoit, Y., Mauvieux, L., Lutz, P., Mechinaud, F., Grardel, N., Mazingue, F., Dupont, M., Margueritte, G., Pages, M.P., Bertrand, Y., Plouvier, E., Brunie, G., Bastard, C., Plantaz, D., Vande Velde, I., Hagemeijer, A., Speleman, F., Lessard, M., Otten, J., Vilmer, E. Dastugue, N. (2004) Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood, 103, 442 450.
22. Cossman, J., Chused, T.M., Fisher, R.I., Magrath, I., Bollum, F. Jaffe, E.S. (1983) Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Research, 43, 4486 4490.
23. Coustan-Smith, E., Sandlund, J.T., Perkins, S.L., Chen, H., Chang, M., Abromowitch, M. Campana, D. (2009a) Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group. Journal of Clinical Oncology, 27, 3533 3539.
24. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. Campana, D. (2009b) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncology, 10, 147 156.
25. Crist, W.M., Shuster, J.J., Falletta, J., Pullen, D.J., Berard, C.W., Vietti, T.J., Alvarado, C.S., Roper, M.A., Prasthofer, E. Grossi, C.E. (1988) Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood, 72, 1891 1897.
26. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 7942 7950.
27. Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T.C., Smith, S.D. Sklar, J. (1991) TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66, 649 661.
28. Ferrando, A.A. Look, A.T. (2003) Gene expression profiling in T-cell acute lymphoblastic leukemia. Seminars in Hematology, 40, 274 280.
29. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., Pui, C.H., Downing, J.R., Gilliland, D.G., Lander, E.S., Golub, T.R. Look, A.T. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1, 75 87.
30. Ferrando, A.A., Neuberg, D.S., Dodge, R.K., Paietta, E., Larson, R.A., Wiernik, P.H., Rowe, J.M., Caligiuri, M.A., Bloomfield, C.D. Look, A.T. (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet, 363, 535 536.
31. Flohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grumayer, R., van der Velden, V., Fischer, S., Stanulla, M., Basso, G., Niggli, F.K., Schafer, B.W., Sutton, R., Koehler, R., Zimmermann, M., Valsecchi, M.G., Gadner, H., Masera, G., Schrappe, M., van Dongen, J.J., Biondi, A. Bartram, C.R. (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22, 771 782.
32. Foroni, L., Sorour, A. Sinclair P, D.V. (2003) Loss of heterozygosity (LOH) and microsatellite instability (MSI) of chromosme 6q16-21 identifies a prognostically poor group of childhood and adult T cell acute lymphoblastic leukemia (ALL) patients. Abstract. Blood, 102, 606.
33. Freedman, A.S. (1996) Cell surface antigens in leukemias and lymphomas. Cancer Investigation, 14, 252 276.
34. Goldberg, J.M., Silverman, L.B., Levy, D.E., Dalton, V.K., Gelber, R.D., Lehmann, L., Cohen, H.J., Sallan, S.E. Asselin, B.L. (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. Journal of Clinical Oncology, 21, 3616 3622.
35. van Grotel, M., Meijerink, J.P., Beverloo, H.B., Langerak, A.W., Buys-Gladdines, J.G., Schneider, P., Poulsen, T.S., den Boer, M.L., Horstmann, M., Kamps, W.A., Veerman, A.J., van Wering, E.R., van Noesel, M.M. Pieters, R. (2006) The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica, 91, 1212 1221.
36. van Grotel, M., van den Heuvel-Eibrink, M.M., van Wering, E.R., van Noesel, M.M., Kamps, W.A., Veerman, A.J., Pieters, R. Meijerink, J.P. (2008a) CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatric Blood and Cancer, 51, 737 740.
37. van Grotel, M., Meijerink, J.P., van Wering, E.R., Langerak, A.W., Beverloo, H.B., Buijs-Gladdines, J.G., Burger, N.B., Passier, M., van Lieshout, E.M., Kamps, W.A., Veerman, A.J., van Noesel, M.M. Pieters, R. (2008b) Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia, 22, 124 131.
38. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T., Isaacson, P., Knowles, D., Mason, D., Muller-Hermelink, H., Pileri, S., Piris, M., Ralfkiaer, E. Warnke, R. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361 1392. (Pubitemid 24273002)
39. Hayashi, Y., Raimondi, S.C., Look, A.T., Behm, F.G., Kitchingman, G.R., Pui, C.H., Rivera, G.K. Williams, D.L. (1990) Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood, 76, 1626 1630.
40. Head, D.R. Behm, F.G. (1995) Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood. Seminars in Diagnostic Pathology, 12, 325 334.
41. Heerema, N.A., Sather, H.N., Sensel, M.G., Kraft, P., Nachman, J.B., Steinherz, P.G., Lange, B.J., Hutchinson, R.S., Reaman, G.H., Trigg, M.E., Arthur, D.C., Gaynon, P.S. Uckun, F.M. (1998) Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. Journal of Clinical Oncology, 16, 1270 1278. (Pubitemid 28175739)
42. Heerema, N.A., Sather, H.N., Sensel, M.G., Lee, M.K., Hutchinson, R., Lange, B.J., Bostrom, B.C., Nachman, J.B., Steinherz, P.G., Gaynon, P.S. Uckun, F.M. (2000) Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Leukaemia & Lymphoma, 36, 467 478. (Pubitemid 30103171)
43. Heyman, M., Calero, M.T., Liu, Y., Grander, D., Rasool, O., Borgonova-Brandter, L., Merup, M., Soderhall, S. Einhorn, S. (1997) Inverse correlation between loss of heterozygosity of the short arm of chromosome 12 and p15ink4B/p16ink4 gene inactivation in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 98, 147 150.
44. Hoelzer, D. Gokbuget, N. (2009) T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity? Clinical Lymphoma Myeloma, 9 (Suppl. 3 S214 S221.
45. Kaneko, Y., Frizzera, G., Maseki, N., Sakurai, M., Komada, Y., Hiyoshi, Y., Nakadate, H. Takeda, T. (1988) A novel translocation, t(9;17)(q34;q23), in aggressive childhood lymphoblastic lymphoma. Leukemia, 2, 745 748.
46. Kees, U.R., Burton, P.R., Lu, C. Baker, D.L. (1997) Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood, 89, 4161 4166.
47. Krieger, D., Moericke, A., Oschlies, I., Zimmermann, M., Schrappe, M., Reiter, A. Burkhardt, B. (2009). Frequency and clinical relevance of DNA microsatellite alterations of the CDKN2A/B, ATM and p53 gene loci: a comparison between pediatric precursor T-cell lymphoblastic lymphoma and T-cell lymphoblastic leukemia. Haematologica, doi :.
48. Kuiper, R.P., Schoenmakers, E.F., van Reijmersdal, S.V., Hehir-Kwa, J.Y., van Kessel, A.G., van Leeuwen, F.N. Hoogerbrugge, P.M. (2007) High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia, 21, 1258 1266.
49. Larson Gedman, A., Chen, Q., Kugel Desmoulin, S., Ge, Y., Lafiura, K., Haska, C.L., Cherian, C., Devidas, M., Linda, S.B., Taub, J.W. Matherly, L.H. (2009) The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia, 23, 1417 1425.
50. Lones, M.A., Heerema, N.A., Le Beau, M.M., Sposto, R., Perkins, S.L., Kadin, M.E., Kjeldsberg, C.R., Meadows, A., Siegel, S., Buckley, J., Abromowitch, M., Kersey, J., Bergeron, S., Cairo, M.S. Sanger, W.G. (2007) Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genetics and Cytogenetics, 172, 1 11.
51. Magrath, I.T. (1987) Malignant non-Hodgkin's lymphomas in children. Hematology/Oncology Clinics of North America, 1, 577 602.
52. Malyukova, A., Dohda, T., von der Lehr, N., Akhoondi, S., Corcoran, M., Heyman, M., Spruck, C., Grander, D., Lendahl, U. Sangfelt, O. (2007) The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Research, 67, 5611 5616.
53. Mancini, M., Vegna, M.L., Castoldi, G.L., Mecucci, C., Spirito, F., Elia, L., Tafuri, A., Annino, L., Pane, F., Rege-Cambrin, G., Gottardi, M., Leoni, P., Gallo, E., Camera, A., Luciano, L., Specchia, G., Torelli, G., Sborgia, M., Gabbas, A., Tedeschi, A., Della Starza, I., Cascavilla, N., Di Raimondo, F., Mandelli, F. Foa, R. (2002) Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia, 16, 2055 2061.
54. Merup, M., Moreno, T.C., Heyman, M., Ronnberg, K., Grander, D., Detlofsson, R., Rasool, O., Liu, Y., Soderhall, S., Juliusson, G., Gahrton, G. Einhorn, S. (1998) 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood, 91, 3397 3400.
55. Mitchell, C.D., Gordon, I. Chessells, J.M. (1986) Clinical, haematological, and radiological features in T-cell lymphoblastic malignancy in childhood. Clinical Radiology, 37, 257 261.
56. Moreno, T.C., Widell, S., Czader, M., Grander, D., Soderhall, S., Gustafsson, G., Einhorn, S., Porwit, A. Heyman, M. (2000) Inverse correlation between Ink4-locus deletions and ICM-DNA hyperdiploidy in childhood acute lymphoblastic leukaemia, relation to clinical characteristics and outcome. European Journal of Haematology, 65, 390 398.
57. Moricke, A., Zimmermann, M., Reiter, A., Gadner, H., Odenwald, E., Harbott, J., Ludwig, W.D., Riehm, H. Schrappe, M. (2005) Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klinische Padiatrie, 217, 310 320.
58. Moricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dordelmann, M., Loning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. Schrappe, M. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 4477 4489.
59. Mullighan, C.G., Goorha, S., Radtke, I., Miller, C.B., Coustan-Smith, E., Dalton, J.D., Girtman, K., Mathew, S., Ma, J., Pounds, S.B., Su, X., Pui, C.H., Relling, M.V., Evans, W.E., Shurtleff, S.A. Downing, J.R. (2007) Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 446, 758 764.
60. Murre, C. (2005) Helix-loop-helix proteins and lymphocyte development. Nature Immunology, 6, 1079 1086.
61. Niehues, T., Kapaun, P., Harms, D.O., Burdach, S., Kramm, C., Korholz, D., Janka-Schaub, G. Gobel, U. (1999) A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia, 13, 614 617.
62. Okuda, T., Shurtleff, S.A., Valentine, M.B., Raimondi, S.C., Head, D.R., Behm, F., Curcio-Brint, A.M., Liu, Q., Pui, C.H. Sherr, C.J. (1995) Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321 2330.
63. Palomero, T., Sulis, M.L., Cortina, M., Real, P.J., Barnes, K., Ciofani, M., Caparros, E., Buteau, J., Brown, K., Perkins, S.L., Bhagat, G., Agarwal, A.M., Basso, G., Castillo, M., Nagase, S., Cordon-Cardo, C., Parsons, R., Zuniga-Pflucker, J.C., Dominguez, M. Ferrando, A.A. (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nature Medicine, 13, 1203 1210.
64. Park, M.J., Taki, T., Oda, M., Watanabe, T., Yumura-Yagi, K., Kobayashi, R., Suzuki, N., Hara, J., Horibe, K. Hayashi, Y. (2009) FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. British Journal of Haematology, 145, 198 206.
65. Pillon, M., Piglione, M., Garaventa, A., Conter, V., Giuliano, M., Arcamone, G., Mura, R., Cellini, M., D'Amore, E.S., Varotto, S., Mussolin, L. Rosolen, A. (2009) Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of pediatric hematology and oncology. Pediatric Blood and Cancer, 53, 953 959.
66. Pui, C.H., Sandlund, J.T., Pei, D., Campana, D., Rivera, G.K., Ribeiro, R.C., Rubnitz, J.E., Razzouk, B.I., Howard, S.C., Hudson, M.M., Cheng, C., Kun, L.E., Raimondi, S.C., Behm, F.G., Downing, J.R., Relling, M.V. Evans, W.E. (2004) Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood, 104, 2690 2696.
67. Pullen, J., Shuster, J.J., Link, M., Borowitz, M., Amylon, M., Carroll, A.J., Land, V., Look, A.T., McIntyre, B. Camitta, B. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. a Pediatric Oncology Group (POG) study. Leukemia, 13, 1696 1707.
68. Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H.R. Aguet, M. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity, 10, 547 558.
69. Raetz, E.A., Perkins, S.L., Bhojwani, D., Smock, K., Philip, M., Carroll, W.L. Min, D.J. (2006) Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatric Blood and Cancer, 47, 130 140.
70. Raimondi, S.C., Behm, F.G., Roberson, P.K., Pui, C.H., Rivera, G.K., Murphy, S.B. Williams, D.L. (1988) Cytogenetics of childhood T-cell leukemia. Blood, 72, 1560 1566.
71. Ramakers-van Woerden, N.L., Pieters, R., Slater, R.M., Loonen, A.H., Beverloo, H.B., van, D.E., Heyman, M., Moreno, T.C., Rots, M.G., van Wering, E.R., Kamps, W.A., Janka-Schaub, G.E. Veerman, A.J. (2001) In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia. British Journal of Haematology, 112, 680 690.
72. Real, P.J. Ferrando, A.A. (2009) NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia, 23, 1374 1377.
73. Reiter, A., Schrappe, M., Tiemann, M., Parwaresch, R., Zimmermann, M., Yakisan, E., Dopfer, R., Bucsky, P., Mann, G., Gadner, H. Riehm, H. (1994) Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. Journal of Clinical Oncology, 12, 899 908.
74. Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology, 13, 359 372.
75. Reiter, A., Schrappe, M., Ludwig, W.D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H. Riehm, H. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 95, 416 421.
76. Remke, M., Pfister, S., Kox, C., Toedt, G., Becker, N., Benner, A., Werft, W., Breit, S., Liu, S., Engel, F., Wittmann, A., Zimmermann, M., Stanulla, M., Schrappe, M., Ludwig, W.D., Bartram, C.R., Radlwimmer, B., Muckenthaler, M.U., Lichter, P. Kulozik, A.E. (2009) High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-[beta] and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood, 114, 1053 1062.
77. Rubnitz, J.E., Behm, F.G., Pui, C.H., Evans, W.E., Relling, M.V., Raimondi, S.C., Harrison, P.L., Sandlund, J.T., Ribeiro, R.C., Grosveld, G. Downing, J.R. (1997) Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia, 11, 1201 1206.
78. Sandlund, J., Marcus, K. Behm, F. (2003) Management of lymphoma in children. In : Non-Hodgkin's Lymphoma (ed. by Mauch, P., Armitage, J., Coiffier, B., Dalla-Favera, R. Harris, N. pp. 575 597. Lippincott Williams & Wilkins
79. Sandlund, J.T., Pui, C.H., Zhou, Y., Behm, F.G., Onciu, M., Razzouk, B.I., Hijiya, N., Campana, D., Hudson, M.M. Ribeiro, R.C. (2009) Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia, 23, 1127 1130.
80. Schabath, R., Ratei, R. Ludwig, W.D. (2003) The prognostic significance of antigen expression in leukaemia. Best Practice and Research. Clinical Haematology, 16, 613 628.
81. Schneider, N.R., Carroll, A.J., Shuster, J.J., Pullen, D.J., Link, M.P., Borowitz, M.J., Camitta, B.M., Katz, J.A. Amylon, M.D. (2000) New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood, 96, 2543 2549.
82. Schraders, M., van Reijmersdal, S.V., Kamping, E.J., van Krieken, J.H., van Kessel, A.G., Groenen, P.J., Hoogerbrugge, P.M. Kuiper, R.P. (2009) High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genetics and Cytogenetics, 191, 27 33.
83. Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., Kornhuber, B., Ritter, J., Welte, K., Gadner, H. Riehm, H. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 95, 3310 3322.
84. Seibel, N.L., Steinherz, P.G., Sather, H.N., Nachman, J.B., Delaat, C., Ettinger, L.J., Freyer, D.R., Mattano, Jr., L.A., Hastings, C.A., Rubin, C.M., Bertolone, K., Franklin, J.L., Heerema, N.A., Mitchell, T.L., Pyesmany, A.F., La, M.K., Edens, C. Gaynon, P.S. (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood, 111, 2548 2555.
85. Sheibani, K., Nathwani, B.N., Winberg, C.D., Burke, J.S., Swartz, W.G., Blayney, D., van de Velde, S., Hill, L.R. Rappaport, H. (1987) Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer, 60, 183 190.
86. Shikano, T., Ishikawa, Y., Naito, H., Kobayashi, R., Nakadate, H., Hatae, Y. Takeda, T. (1992) Cytogenetic characteristics of childhood non-Hodgkin lymphoma. Cancer, 70, 714 719.
87. Smock, K.J., Nelson, M., Tripp, S.R., Sanger, W.G., Abromowitch, M., Cairo, M.S. Perkins, S.L. (2008) Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatric Blood and Cancer, 51, 489 494.
88. Stark, B., Avigad, S., Luria, D., Manor, S., Reshef-Ronen, T., Avrahami, G. Yaniv, I. (2009) Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR). Pediatric Blood and Cancer, 52, 20 25.
89. Sun, X.F., Xia, Z.J., Zhen, Z.J., Xiang, X.J., Xia, Y., Ling, J.Y., Liu, D.G., Huang, H.Q., Zhen, L., Luo, W.B., Lin, H. Guan, Z.Z. (2008) Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma. International Journal of Clinical Oncology, 13, 436 441.
90. Sweetenham, J. Borowitz, M. (2003) Precursor B-and T-cell lymphoblastic lymphoma. In : Non-Hodgkin's Lymphoma (ed. by Mauch, P., Armitage, J., Coiffier, B., Dalla-Favera, R. Harris, N. pp. 503 513. Lippincott Williams & Wilkins
91. Takeuchi, S., Koike, M., Seriu, T., Bartram, C.R., Schrappe, M., Reiter, A., Park, S., Taub, H.E., Kubonishi, I., Miyoshi, I. Koeffler, H.P. (1998) Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Research, 58, 2618 2623.
92. Takeuchi, S., Tsukasaki, K., Bartram, C.R., Seriu, T., Zimmermann, M., Schrappe, M., Takeuchi, N., Park, S., Taguchi, H. Koeffler, H.P. (2003) Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia, 17, 149 154.
93. Thiel, E., Kranz, B.R., Raghavachar, A., Bartram, C.R., Loffler, H., Messerer, D., Ganser, A., Ludwig, W.D., Buchner, T. Hoelzer, D. (1989) Prethymic phenotype and genotype of pre-T (CD7+/ER-) cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood, 73, 1247 1258.
94. Uckun, F.M., Gaynon, P.S., Sensel, M.G., Nachman, J., Trigg, M.E., Steinherz, P.G., Hutchinson, R., Bostrom, B.C., Sather, H.N. Reaman, G.H. (1997) Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. Journal of Clinical Oncology, 15, 2214 2221.
95. Uyttebroeck, A., Vanhentenrijk, V., Hagemeijer, A., Boeckx, N., Renard, M., Wlodarska, I., Vandenberghe, P., Depaepe, P. de Wolf-Peeters, C. (2007) Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma? Leukaemia & Lymphoma, 48, 1745 1754.
96. Uyttebroeck, A., Suciu, S., Laureys, G., Robert, A., Pacquement, H., Ferster, A., Marguerite, G., Mazingue, F., Renard, M., Lutz, P., Rialland, X., Mechinaud, F., Cave, H., Baila, L. Bertrand, Y. (2008) Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. European Journal of Cancer, 44, 840 846.
97. Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 2257 2266.
98. Walters, R., Kantarjian, H.M., Keating, M.J., Estey, E.H., Trujillo, J., Cork, A., McCredie, K.B. Freireich, E.J. (1990) The importance of cytogenetic studies in adult acute lymphocytic leukemia. American Journal of Medicine, 89, 579 587.
99. Weiss, L.M., Bindl, J.M., Picozzi, V.J., Link, M.P. Warnke, R.A. (1986) Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood, 67, 474 478.
100. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269 271.
101. Williams, A.H., Taylor, C.R., Higgins, G.R., Quinn, J.J., Schneider, B.K., Swansson, V., Parker, J.W., Pattengale, P.K., Chandor, S.B., Powars, D., Lincoln, T.L., Tindle, B.H. Lukes, R.J. (1978) Childhood lymphoma-leukemia. I. Correlation of morphology and immunological studies. Cancer, 42, 171 181.
102. Wolfer, A., Wilson, A., Nemir, M., MacDonald, H.R. Radtke, F. (2002) Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. Immunity, 16, 869 879.
103. Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133 143.
104. Zhou, M., Gu, L., Yeager, A.M. Findley, H.W. (1997) Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 14, 141 150.
105. Zhu, Y.M., Zhao, W.L., Fu, J.F., Shi, J.Y., Pan, Q., Hu, J., Gao, X.D., Chen, B., Li, J.M., Xiong, S.M., Gu, L.J., Tang, J.Y., Liang, H., Jiang, H., Xue, Y.Q., Shen, Z.X., Chen, Z. Chen, S.J. (2006) NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in